It is down 18.66% since October 13, 2016 and is uptrending. It has outperformed by 87.21% the S&P500. For BMY, the company now has $3.47 Billion of cash on the books, which is offset by $1.31 Billion current liabilities. First Manhattan Co.'s holdings in Bristol-Myers Squibb were worth $16,901,000 as of its most recent filing with the Securities & Exchange Commission. Fiduciary Tru reported 2,777 shares stake. It has underperformed by 39.89% the S&P500. Welch Investments LLC increased its position in Bristol-Myers Squibb by 3.9% during the 1st quarter. The Nelson Roberts Investment Advisors Llc holds 86,740 shares with $4.83 million value, up from 2,400 last quarter. BMY's profit would be $1.23B giving it 21.78 P/E if the $0.75 EPS is correct. During the same quarter in the previous year, the firm earned $0.69 EPS.
Covering sell-side analysts have recently weighed in on shares of Bristol-Myers Squibb Company (NYSE:BMY). Therefore 0 are positive. William Blair reiterated an outperform rating on shares of Bristol-Myers Squibb in a research report on Monday, June 26th.
Since the beginning of the calendar year, the stock is 11.82%. On Monday, August 14 the stock rating was maintained by Cowen & Co with "Hold". The rating was maintained by Citigroup with "Buy" on Tuesday, September 20. BMO Capital Markets maintained Bristol-Myers Squibb Co (NYSE:BMY) on Sunday, July 23 with "Sell" rating. The firm earned "Hold" rating on Tuesday, March 15 by Jefferies. The firm has "Hold" rating given on Wednesday, August 16 by Credit Suisse.
Investors sentiment decreased to 0.95 in 2017 Q2. Its up 0.07, from 0.82 in 2017Q1.
Hedge funds have recently added to or reduced their stakes in the company. The Georgia-based Advisory Svcs Network Limited Liability has invested 0.16% in Bristol-Myers Squibb Co (NYSE:BMY). Hutchinson Capital Management Ca reported 3,930 shares or 0.06% of all its holdings.
Traders are a little more bullish on Bristol-Myers Squibb Company of late if you consider the change in short interest. Emerald Mutual Fund Advisers invested in 0.38% or 648,075 shares. On average, equities analysts predict that Bristol-Myers Squibb Company will post $2.98 EPS for the current fiscal year. Shayne & CO. LLC lifted its holdings in Bristol-Myers Squibb by 0.6% in the second quarter. During the last 52 weeks, the price has been as high as $65.73 and as low as $46.01. Finally, Physicians Financial Services Inc. raised its position in Bristol-Myers Squibb by 0.4% during the first quarter. Illinois-based High Pointe Limited Com has invested 2.31% in Bristol-Myers Squibb Co (NYSE:BMY). Smithfield Trust holds 0.17% or 20,240 shares. When analyzing small corporations as possible investments, always it's good to learn who else owns shares.
In other news, Director Theodore R. Samuels II acquired 6,000 shares of Bristol-Myers Squibb stock in a transaction that occurred on Wednesday, August 2nd.
Cmt Asset Management Ltd increased Vaneck Vectors Etf Tr (Call) stake by 488,800 shares to 668,800 valued at $18.06 million in 2017Q2. It also reduced Spon Adr (Put) stake by 15,400 shares and now owns 30,000 shares. One analyst has rated the stock with a sell rating, eight have given a hold rating and eleven have given a buy rating to the stock. Therefore 33% are positive. Torchmark Corporation had 26 analyst reports since July 29, 2015 according to SRatingsIntel. The company was upgraded on Friday, January 22 by Berenberg. As per Monday, June 26, the company rating was maintained by H.C. Wainwright. Keefe Bruyette & Woods downgraded Walker & Dunlop, Inc. On Wednesday, November 4 the stock rating was maintained by RBC Capital Markets with "Sector Perform". JMP Securities upgraded Walker & Dunlop, Inc. (NYSE:WD) rating on Thursday, August 6. The company was maintained on Friday, April 7 by Wood. Keefe Bruyette & Woods maintained Walker & Dunlop, Inc. The rating was maintained by Jefferies on Thursday, July 14 with "Hold".
FCF is an indicator of a firm's financial performance, measured as operating cash flow minus capital expenditures.
A statistical measure of the dispersion of returns (volatility) for BMY producing salvation in Investors mouth, it has week volatility of 1.33% and for the month booked as 1.24%. Its down 0.25, from 1.09 in 2017Q1. There were 81 sold out positions, amounting to 11.08 million shares. 49 funds opened positions while 105 raised stakes.
Kura Oncology, Inc. (KURA) stock moved with shift of 0.36% in the past week. (NYSE:WD) for 186,451 shares. Essex Inv Mgmt Co Ltd Liability Co accumulated 122,397 shares. 140,668 are owned by Penn Davis Mcfarland Incorporated. Being disciplined is an attribute that many successful investors share. (NYSE:WD). Price T Rowe Md invested 0% of its portfolio in Walker & Dunlop, Inc. Strategic Advsr Limited accumulated 37,808 shares. Putnam Invs Llc invested 0% in Walker & Dunlop, Inc. 13,500 are owned by Hutchin Hill Cap Ltd Partnership. (NYSE:WD) for 35,000 shares. Mackenzie Financial reported 425,196 shares.